INOVIO, a biotechnology company specializing in DNA medicines for HPV-related diseases, cancer, and infectious diseases, announced its participation in two upcoming investor conferences: the Jefferies Global Healthcare Conference in London on November 18, 2026, and the Piper Sandler 38th Annual Healthcare Conference in New York on December 1, 2026. The company will deliver presentations and engage in one-on-one meetings with investors, with webcasts available for replay for 90 days. These events provide INOVIO an opportunity to update investors on its progress and future plans in DNA medicine development.
INOVIO's participation in upcoming investor conferences comes as its stock trades at USD 1.31 on Pluang as of Nov 11, 2026 20:11 WIB, down 10.54% for the day. This price is closer to its 52-week low of USD 0.60 than its high of USD 2.60, indicating a significant range in recent performance. Despite the drop, the majority of Pluang investors remain buyers with 72% buy orders versus 28% sell orders, and the typical holding period is 41 days.
